Rapid Itch Relief with Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3b/4 Level Up Study
SKIN The Journal of Cutaneous Medicine · 10.03.2026 · 10 (2) · s735
DOI: 10.25251/078a3s70 ↗Kurz gefasst
Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.03.2026. Verfasst von Christopher Bunick und 10 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Itch is the hallmark symptom of atopic dermatitis (AD). We evaluated itch improvement with upadacitinib (a selective oral Janus kinase inhibitor) vs dupilumab (an injectable monoclonal antibody that inhibits interleukin 4 and interleukin 13 signaling) in patients with moderate-to-severe AD.
Methods
In Level Up (NCT05601882), a phase 3b/4, global, open-label, efficacy assessor blinded study, patients (≥12 and 1, respectively, daily through Day 28 (i.e., prior to potential upadacitinib dose escalation). Non-responder imputation was used to handle missing data. Nominal p-values are reported.
Results
A greater proportion of upadacitinib-treated patients (upadacitinib vs dupilumab; nominal p-value) achieved ∆WP-NRS≥4 as early as Day 2 (9.4% vs 3.5%; 0.0003) and increased through Day 28 (50.8% vs 29.3%;
Zitieren
APA
Bunick, C., Kwatra, S., Lima, H., Abe, M., Song, E. J., Ibrahim, N., Sanchez, C. S., Vigna, N., Lane, M., Calimlim, B., & Ständer, S. (2026). Rapid Itch Relief with Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3b/4 Level Up Study. SKIN The Journal of Cutaneous Medicine, 10(2), s735. https://doi.org/10.25251/078a3s70
Vancouver
Bunick C, Kwatra S, Lima H, Abe M, Song EJ, Ibrahim N, et al. Rapid Itch Relief with Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3b/4 Level Up Study. SKIN The Journal of Cutaneous Medicine. 2026;10(2):s735. doi:10.25251/078a3s70
BibTeX
@article{Bunick2026,
author = {Bunick, Christopher and Kwatra, Shawn and Lima, Hermenio and Abe, Masatoshi and Song, Eingun James and Ibrahim, Nadia and Sanchez, Cristina Sancho and Vigna, Namita and Lane, Michael and Calimlim, Brian and Ständer, Sonja},
title = {Rapid Itch Relief with Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3b/4 Level Up Study},
journal = {SKIN The Journal of Cutaneous Medicine},
year = {2026},
volume = {10},
number = {2},
pages = {s735},
doi = {10.25251/078a3s70}
}
EUVIMED